The effect of the endothelin ET(A) receptor antagonist CI-1020 on hypoxic pulmonary vasoconstriction

European Journal of Pharmacology

Volumn 374, Issue 3, 1999, Pages 367-375

  Jones, Richard D ^a   Wanstall, Janet C ^b   Gambino, Agatha ^b   Morice, Alyn H ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CI 1020; Endothelin ET(A) receptor; Endothelin ET(B2) receptor; Endothelin 1; Hypoxic pulmonary vasoconstriction; Pulmonary artery

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PHENYLEPHRINE; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; VASODILATATION;

ANIMALS; ANOXIA; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; MALE; PULMONARY ARTERY; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; VASOCONSTRICTION;

EID: 0033045445     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00300-3     Document Type: Article

References (45)

1. Bialecki R.A., Fisher C.S., Murdoch W.W., Barthlow H.G., Bertelsen D.L. Functional comparison of endothelin receptors in human and rat pulmonary artery smooth muscle. Am. J. Physiol. 272:1997;L211-L218.
2. A receptor antagonist attenuates hypoxic pulmonary hypertension in rats. Am. J. Physiol. 266:1994;H1327-H1331.
3. Chen S.J., Meng Q.C., Yano M., Oparil S., Chen Y.F. Endothelin A receptor antagonism prevents acute hypoxia induced pulmonary hypertension in rats. FASEB J. 7:1993;A649.
4. Chen S.J., Chen Y.F., Meng Q.C. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl. Physiol. 79:1995;2122-2131.
5. Chen S.J., Chen Y.F., Openorth T.J., Wessale J.T., Meng Q.C., Durand J., DiCarlo V.S., Oparil S. The orally active non-peptide endothelin A receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodelling in Sprague-Dawley rats. J. Cardiovasc. Pharmacol. 29:1997;713-725.
6. A receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in the rat. Am. J. Physiol. 269:1995;L690-L697.
7. Douglas S.A., Vickery-Clark L.M., Ohlstein E.H. Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ123. Br. J. Pharmacol. 108:1993;418-421.
8. Giaid A., Yanagisawa M., Langleben D., Michel R.P., Levy R., Shennib H., Kimura S., Masaki T., Duguid W.P., Path T.C., Stewart D.J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328:1993;1732-1739.
9. Goerre S., Wenk M., Bartch P., Luscher T.F., Niroomand F., Hohenhaus E., Oelz O., Reinhart W.H. Endothelin-1 in pulmonary hypertension associated with high exposure. Circulation. 91:1995;359-364.
10. Helset E., Kjaeve J., Bjertnaes L., Lundberg J.M. Acute alveolar hypoxia increases endothelin-1 release but decreases release of calcitonin gene-related peptide in isolated perfused rat lungs. Scand. J. Clin. Invest. 55:1995;369-376.
11. Higashi T., Ishizaki T., Shigemori K., Nakai T., Miyabo S., Inui T., Yamamura T. Pharmacological heterogeneity of constrictions mediated by endothelin receptors in rat pulmonary arteries. Am. J. Physiol. 272:1997;L287-L293.
12. Holm P. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction. Scand. Cardiovasc. J. 31:1997;S46.
13. 2+ ion. J. Appl. Physiol. 65:1988;2468-2478.
14. A receptors do not modulate acute hypoxic pulmonary vasoconstriction. Appl. Cardiopulm. Pathophysiol. 5:1995;153-159.
15. Kitamura K., Tanaka T., Kato J., Eto T., Tanaka K. Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney. Biochem. Biophys. Res. Commun. 161:1989;348-352.
16. Koseki C., Imai M., Hirata Y., Yanagisawa M., Masaki T. Bindings sites for endothelin-1 in rat tissues: an autoradiographic study. J. Cardiovasc. Pharmacol. 13:1989;S153-S154.
17. Lazor R., Feihl F., Waeber B., Kucera P., Perret C. Endothelin-1 does not mediate the endothelium dependent hypoxic contractions of small pulmonary arteries in rats. Chest. 110:1996;189-197.
18. MacLean M.R., McCulloch K.M. Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia. Br. J. Pharmacol. 123:1998;991-999.
19. B mediated vasoconstriction in rat pulmonary arteries and arterioles. J. Cardiovasc. Pharmacol. 23:1994;838-854.
20. A selective non-peptide antagonist PD156707 for endothelin receptors in human renal and cardiovascular tissues. Br. J. Pharmacol. 117, 35 p.
21. B receptors. J. Pharmacol. Exp. Ther. 280:1997;1102-1108.
22. O'Donnell S.R., Kay K.S. Effects of endothelin receptor selective antagonists, BQ123 and BQ788 on IRL 1620 and endothelin-1 responses of airway and vascular preparations from rats. Pulm. Pharmacol. 8:1995;11-19.
23. Oparil S., Chen S.J., Meng Q.C., Elton T.S., Yano M., Chen Y.F. Endothelin-A receptor antagonism prevents acute hypoxia-induced pulmonary hypertension in the rat. Am. J. Physiol. 268:1995;L95-L100.
24. Patt C.W., Edmunds J.J., Repine J.T., Berryman K.A., Reisdorph B.R., Lee C., Plummer M.S., Shahripour A., Haleen S.J., Keiser J.A., Flynn M.A., Welch K.M., Reynolds E.E., Rubin R., Tobias B., Hallack H., Doherty A.M. Structure-activity relationships in a series of orally active γ-hydroxy butenolide endothelin antagonists. J. Med. Chem. 40:1997;1063-1074.
25. Post J.M., Hume J.R., Archer S.L., Weir E.K. Direct role of potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am. J. Physiol. 262:1992;C882-C890.
26. Robertson B.E., Corry P.R., Nye P.C.G., Kozlowski R.Z. Calcium and magnesium-ATP activated potassium channels from rat pulmonary artery. Pfluegers Arch. 421:1992;94-96.
27. Rogers T.K., Morice A.H. Inhibition of hypoxic pulmonary vasoconstriction in isolated small pulmonary arteries by ANP. Am. Rev. Respir. Dis. 147:1993;A724.
28. Rogers T.K., Stewart G., Morice A.H. Effect of chronic hypoxia on rat pulmonary resistance vessels; vasodilation by atrial natriuretic peptide. Clin. Sci. 83:1992;723-729.
29. + currents in myocytes isolated from aorta, basilar and pulmonary artery. J. Pharmacol. Exp. Ther. 284:1998;1122-1131.
30. Sasaki S.-I., Kobayashi N., Dambara T., Kira S., Sakai T. Structural organisation of pulmonary arteries in the rat lung. Anat. Embryol. 191:1995;477-489.
31. Shimoda L.A., Sylvester J.T., Sham J. Inhibition of voltage gated potassium current in rat intrapulmonary arterial myocytes by endothelin-1. Am. J. Physiol. 274:1998;L842-L853.
32. Shimoda T., Booth G., Liu Q., Shimoda L., Sham J., Sylvester J.T. Endothelium-dependent hypoxic contraction of pig proximal intrapulmonary arteries: role of endothelin. Am. J. Respir. Crit. Care Med. 157:1998;A724.
33. Shirakami G., Nakao K., Saito Y., Magaribuchi T., Jougasaki M., Mukoyama M., Arai H., Hoseoda K., Suda S., Ogawa Y., Yamada T., Mori K., Imura H. Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 in conscious rats. Life Sci. 48:1991;969-976.
34. Stewart J.D., Levy R.D., Cernacek P., Langeleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann. Intern. Med. 114:1991;464-469.
35. Takeoka M., Ishizaki T., Sakai A., Chang S.W., Shigemori K., Higashi T., Ueda G. Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs. Acta Physiol. Scand. 155:1995;53-60.
36. Teng G.Q., Barer G.R. Vasoconstrictor and vasodilator effects of hypoxia in rat lung resistance vessels in vitro. J. Physiol. 475P:1994;121.
37. 2 in small isolated rat lung vessels. J. Physiol. 487P:1995;110.
38. Turner J.L., Kozlowski R.Z. Relationship between membrane potential, delayed rectifier potassium currents and hypoxia in rat pulmonary arterial myocytes. Exp. Physiol. 82:1997;629-645.
39. Von Euler U.S., Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol. Scand. 12:1946;301-320.
40. B smooth muscle receptors from rat and rabbit. FASEB J. 9:1995;A936.
41. Walker S.D., Edwards G., Weston A.H. The function effects of potassium channel modulation in rat pulmonary artery by hypoxia and 4-aminopyridine. N-S. Arch. Pharmacol. 358:1998;R705.
42. ATP channels. Eur. J. Pharmacol. 303:1996;71-78.
43. Wanstall J.C., Hughes I.E., O'Donnell S.R. Evidence that nitric oxide from the endothelium attenuates inherent tone in isolated pulmonary arteries from rats with hypoxic pulmonary hypertension. Br. J. Pharmacol. 114:1995;109-114.
44. Woodmansey P.A., Zhang F., Channer K.S., Morice A.H. Variation in the sensitivity of hypoxic pulmonary vasoconstriction to amlodipine according to phase and vessel. Thorax. 48:1993;465-466.
45. Yanagisawa M., Kiruhara H., Kimura S., Tomobe Y., Kobyashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.